+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urinary Incontinence Treatment Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327994
  • Report
  • February 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Allergan, Inc.
  • Astellas Pharma, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
Urinary incontinence is considered to be the variety of abnormalities occurs in the urinary tract that results in to experiencing normal micturition. This leads to involuntary loss of bladder control. Approximately 40% of community-dwelling elderly and hospitalized patients are afflicted with this disorder and the remaining 60% of nursing home patients experience this disorder, and it is often the reason for their admittance. The causes of urinary incontinence are numerous and involves age-related changes in the bladder and urethra, including decline in outlet resistance in females and prostate enlargement in males.

In urinary incontinence, muscles around urethra do not work in the way they should, resulting in leak-out of urine. There are various types of incontinences such as stress (bladder is under pressure), urge (intense urge to pass urine), and overflow (chronic urinary retention). The severity of urinary incontinence varies as per health conditions such as urinary tract infection (UTI), constipation, and age group, as urinary incontinence is found more in geriatric population.

Market Dynamics

The urinary incontinence treatment drugs market is expected to drive the market growth during the forecast period, owing to increasing prevalence of urinary incontinence disease. For instance, according to American Urological Association (AUA) 2017 report, more than 200 million people worldwide were affected with stress urinary incontinence (SUI) in 2017, which can seriously affect the quality of life of both men and women. As a disease whose prevalence is related to advancing age, it affects more women than men with an approximate ratio of 3: 1.

Key features of the study:
  • This report provides in-depth analysis of the global urinary incontinence treatment drugs market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global urinary incontinence treatment drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Johnson & Johnson, Pfizer Inc., Astellas Pharma, Inc., Allergan, Inc., Takeda Pharmaceutical Company Limited, Merck & Co., Inc., and Sanofi S.A.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global urinary incontinence treatment drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the urinary incontinence treatment drugs market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:

Global Urinary Incontinence Treatment Drugs Market, By Incontinence Type:
  • Urge Incontinence
  • Stress Incontinence
  • Over-flow Incontinence
  • Mixed Incontinence
  • Other Type
Global Urinary Incontinence Treatment Drugs Market, By Drug Class:
  • Anticholinergic/Antispasmodic Agents
  • Skeletal Muscle Relaxants
  • Antidepressants
  • Alpha Blockers
  • Topical Estrogens
  • Others
Global Urinary Incontinence Treatment Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Urinary Incontinence Treatment Drugs Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Pfizer Inc.
  • Astellas Pharma, Inc.
  • Allergan, Inc.
  • Takeda Pharmaceutical Company Limited
  • Merck & Co., Inc.
  • Sanofi S.A.
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan, Inc.
  • Astellas Pharma, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Incontinence Type
  • Market Snippet, By Drug Class
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • New Lunches and Approvals
  • Pipeline Analysis
  • PEST Analysis
  • Epidemiology
4. Impact Analysis of Covid-19
  • Supply side Analysis
  • Demand Side Analysis
  • Impact on Healthcare Industry
5. Global Urinary Incontinence Treatment Drugs Market, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Urge Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Stress Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Over-flow Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Mixed Incontinence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Other Type
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. Global Urinary Incontinence Treatment Drugs Market, By Drug Class, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Anticholinergic/Antispasmodic Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Skeletal Muscle Relaxants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Antidepressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Alpha Blockers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Topical Estrogens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Global Urinary Incontinence Treatment Drugs Market, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Online Pharmacies
  • Introduction
  • Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
8. Global Urinary Incontinence Treatment Drugs Market, By Region, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, By Region, 2017 - 2027
  • Regional Trends
  • North America
  • Market Size and Forecast, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Latin America
  • Market Size and Forecast, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Asia Pacific
  • Market Size and Forecast, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Incontinence Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
9. Competitive Landscape
  • Company Profiles
  • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Astellas Pharma, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Allergan, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Takeda Pharmaceutical Company Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Merck & Co., Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Sanofi S.A.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
10. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Johnson & Johnson
  • Pfizer Inc.
  • Astellas Pharma, Inc.
  • Allergan, Inc.
  • Takeda Pharmaceutical Company Limited
  • Merck & Co., Inc.
  • Sanofi S.A.
Note: Product cover images may vary from those shown
Adroll
adroll